Daniel Scavilla - GLOBUS MEDICAL-A Executive Vice President Chief Commercial Officer
| GM0N Stock | EUR 85.50 5.00 6.21% |
Insider
Daniel Scavilla is Executive Vice President Chief Commercial Officer of GLOBUS MEDICAL A since 2019.
| Age | 54 |
| Tenure | 6 years |
Daniel Scavilla Latest Insider Activity
Tracking and analyzing the buying and selling activities of Daniel Scavilla against GLOBUS MEDICAL-A stock is an integral part of due diligence when investing in GLOBUS MEDICAL-A. Daniel Scavilla insider activity provides valuable insight into whether GLOBUS MEDICAL-A is net buyers or sellers over its current business cycle. Note, GLOBUS MEDICAL-A insiders must abide by specific rules, including filing SEC forms every time they buy or sell GLOBUS MEDICAL-A'sshares to prevent insider trading or benefiting illegally from material non-public information that their positions give them access to.
Daniel Scavilla over two weeks ago Acquisition by Daniel Scavilla of 30000 shares of Globus Medical at 26.27 subject to Rule 16b-3 | ||
Daniel Scavilla over six months ago Acquisition by Daniel Scavilla of 60000 shares of Globus Medical subject to Rule 16b-3 |
GLOBUS MEDICAL A Leadership Team
Elected by the shareholders, the GLOBUS MEDICAL-A's board of directors comprises two types of representatives: GLOBUS MEDICAL-A inside directors who are chosen from within the company, and outside directors, selected externally and held independent of GLOBUS. The board's role is to monitor GLOBUS MEDICAL-A's management team and ensure that shareholders' interests are well served. GLOBUS MEDICAL-A's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, GLOBUS MEDICAL-A's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Steve Zarrilli, Independent Director | ||
| David Paul, Executive Chairman of the Board | ||
| James Tobin, Independent Director | ||
| Robert Douglas, Independent Director | ||
| Ann Rhoads, Independent Director | ||
| Daniel Lemaitre, Independent Director | ||
| Keith Pfeil, Chief Financial Officer, Senior Vice President | ||
| David Demski, President, Chief Executive Officer, Director | ||
| Kelly Huller, Senior Vice President General Counsel, Corporate Secretary | ||
| Daniel Scavilla, Executive Vice President Chief Commercial Officer | ||
| David Davidar, Independent Director |
GLOBUS Stock Performance Indicators
The ability to make a profit is the ultimate goal of any investor. But to identify the right stock is not an easy task. Is GLOBUS MEDICAL-A a good investment? Although profit is still the single most important financial element of any organization, multiple performance indicators can help investors identify the equity that they will appreciate over time.
| Current Valuation | 6.66 B | |||
| Price To Book | 4.15 X | |||
| Price To Sales | 7.57 X | |||
| Revenue | 1.02 B | |||
| EBITDA | 304.5 M | |||
| Net Income | 190.17 M | |||
| Cash Flow From Operations | 178.47 M | |||
| Price To Earnings To Growth | 2.80 X | |||
| Number Of Employees | 12 | |||
| Market Capitalization | 6.1 B |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.| BTC | Bitcoin | |
| TRX | TRON | |
| BNB | Binance Coin |
Other Information on Investing in GLOBUS Stock
GLOBUS MEDICAL-A financial ratios help investors to determine whether GLOBUS Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in GLOBUS with respect to the benefits of owning GLOBUS MEDICAL-A security.